John Reed is the new Chief Executive Officer at Colorescience, and Mary Fisher, who has led the Company since 2013, is the Vice Chair of the Board as part of a planned leadership succession.
“Mary made Colorescience a brand that healthcare professionals and their patients trust and consumers love, and we’re grateful for everything she has done,” says Amardeep Kahlon, Operating Partner at RoundTable Healthcare Partners and Chairman of the Board at Colorescience, in a news release. “We’re pleased she will stay closely involved as Vice Chair. John has helped grow some of skincare’s most respected dermatologist-recommended brands, and we’re confident he will take what Mary and the team have achieved even further, with our continued investment behind the brand and our professional partners.”
“Leading Colorescience through a remarkable period of growth has been the privilege of my career, and I’m proud of what our team has accomplished,” adds Fisher. “As Vice Chair, I’ll stay focused on our science, our Scientific & Medical Advisory Board, and the professional relationships, which is the heart of what we do. John is the right leader for our next chapter, and I’m fully committed to supporting him and our partners through this transition.”
Reed joins Colorescience after nine years at L’Oréal, most recently as General Manager of Kiehl’s. Prior to that, he led CeraVe both before and after the brand’s sale from Valeant to L’Oréal, heading the brand at Valeant and then serving as General Manager of CeraVe within L’Oréal’s Dermatological Beauty Division.
“I’m excited to join Colorescience, a brand with real clinical credibility and a loyal following,” says Reed. “I’m grateful to Mary for her leadership and her support through this transition. I’ve already enjoyed spending time with our team, and I look forward to meeting the people who rely on our products as we grow our reach with professionals and consumers alike.”